More than two weeks informs doctors and patients.
FDA tracks problems with drug safety.
The New England Journal of Medicine voiced strong concerns.
New study results showed increased risk of heart attacks and stroke in some people.
The Cox-2 inhibitors cause fewer gastrointestinal side effects.
Hints of danger appeared years ago.
Email was released Thursday.
Merck withdrew its arthritis painkiller Vioxx from the market.
Bextra was approved for use for surgery patients.
Safety issues were handled in clinical trials.
Years prevent colon polyps.
The company faced two class action lawsuits.
Earlier less conclusive research raised cardiovascular risk.
